Failure of DIAN-TU drug trial for Alzheimer’s disease

Eli Lilly and F. Hoffman-La Roche announced the failure of the DIAN-TU clinical trial testing two monoclonal antibody drugs for Alzheimer’s disease. Credit: perfectlab on Shutterstock.